PMID- 30621689 OWN - NLM STAT- MEDLINE DCOM- 20190417 LR - 20200225 IS - 1472-6963 (Electronic) IS - 1472-6963 (Linking) VI - 19 IP - 1 DP - 2019 Jan 8 TI - The Harvard medical practice study trigger system performance in deceased patients. PG - 16 LID - 10.1186/s12913-018-3839-6 [doi] LID - 16 AB - BACKGROUND: To detect possible threats to quality and safety, multiple systems have been developed. One of them is retrospective chart review. A team of experts scrutinizes medical records, selected by trigger systems, to detect possible adverse events (AEs). The most important AEs and more hints for possible improvement of care appear in deceased patients. Using triggers in a sample of these patients might increase the performance and lower the burden of scrutinizing records without possible preventable AEs. The aim of this study was therefore to determine the performance of the trigger system in a sample of deceased patients and to calculate the specificity and the sensitivity of this trigger system for predicting AEs. METHODS: We performed a study in which the records of deceased patients were screened for triggers by a team of trained nurses. A sample of 100 medical records was randomly selected out of records which had been screened between 2012 and 2015 for the first time, prior to the study in 2016. For the determination of significant differences between the first and second screening, McNemar's test of symmetry was used. Also, observed agreement, Cohen's Kappa and prevalence-adjusted and-bias-adjusted-kappa (PABAK) statistics were calculated. This was done for the two trigger rounds on both any trigger present and for every trigger separately. RESULTS: The observed agreement for any given trigger was 75% with a Kappa and PABAK of 0.5. For the individual triggers, the observed agreement was on average 90%. The corresponding Kappa was on average 0.42 (range: - 0.03-0.78) and the average PABAK was 0.8 (range: 0.44-0.92). Two adverse events were found in cases without triggers previously. The recalculated specificity and sensitivity for the original population were 58 and 92% respectively. CONCLUSIONS: For the reproducibility of triggers it seems that some perform better than others, but on average this is to our opinion suboptimal. The low specificity implies that many records are selected without AEs. This leads to a high false-positive rate making this labour-intensive record review process costly. Therefore, research for better and more expedient systems is required. FAU - Klein, Dorthe O AU - Klein DO AUID- ORCID: 0000-0003-0182-9569 AD - Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre+, Maastricht, the Netherlands. Dorthe.klein@mumc.nl. FAU - Rennenberg, Roger J M W AU - Rennenberg RJMW AD - Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands. FAU - Koopmans, Richard P AU - Koopmans RP AD - Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands. FAU - Prins, Martin H AU - Prins MH AD - Department of Epidemiology, School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands. LA - eng PT - Journal Article DEP - 20190108 PL - England TA - BMC Health Serv Res JT - BMC health services research JID - 101088677 SB - IM MH - Clinical Audit MH - Data Accuracy MH - *Death MH - Drug-Related Side Effects and Adverse Reactions MH - Humans MH - Medical Errors/*statistics & numerical data MH - Medical Records/*statistics & numerical data MH - Patient Safety/*statistics & numerical data MH - *Precipitating Factors MH - Reproducibility of Results MH - Retrospective Studies MH - *Software PMC - PMC6323723 OTO - NOTNLM OT - Hospital OT - Kappa OT - Medical record review OT - PABAK OT - Reproducibility OT - Triggers COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study protocol was approved by the medical ethics committee of the Maastricht University Medical Centre. Retrospective medical record review of deceased patients is not covered by the WMO. On such retrospective examination, only the Medical Treatment Agreement Act (WGBO) applies and, the Personal Data Protection Act (Wbp) has fallen. Furthermore, it was checked whether the patient included in this study, ever made objections to using their data for study purposes. If so, their data would not have been included. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2019/01/10 06:00 MHDA- 2019/04/18 06:00 PMCR- 2019/01/08 CRDT- 2019/01/10 06:00 PHST- 2017/09/22 00:00 [received] PHST- 2018/12/18 00:00 [accepted] PHST- 2019/01/10 06:00 [entrez] PHST- 2019/01/10 06:00 [pubmed] PHST- 2019/04/18 06:00 [medline] PHST- 2019/01/08 00:00 [pmc-release] AID - 10.1186/s12913-018-3839-6 [pii] AID - 3839 [pii] AID - 10.1186/s12913-018-3839-6 [doi] PST - epublish SO - BMC Health Serv Res. 2019 Jan 8;19(1):16. doi: 10.1186/s12913-018-3839-6.